Document is current
Any future updates will be listed below
-
Authors
Thivat, Emilie http://orcid.org/0000-0001-6833-1971
Rouanet, Jacques
Auzeloux, Philippe
Sas, Nicolas
Jouberton, Elodie
Levesque, Sophie
Billoux, Tommy
Mansard, Sandrine
Molnar, Ioana
Chanchou, Marion
Fois, Giovanna
Maigne, Lydia
Chezal, Jean-Michel
Miot-Noirault, Elisabeth
D’Incan, Michel
Durando, Xavier
Cachin, Florent
-
Funding
Funding for this research was provided by:
Direction de l’hospitalisation et de l’offre de Soins (TRANSLA12-143)
- License Information
-
More Information
Article History
Received: 3 February 2022
Accepted: 6 April 2022
First Online: 15 April 2022
Declarations
:
: The study protocol obtained approval from the French Ethics Committee (Comité de Protection des Personnes Sud Est V, reference: 18-CJPE-01) in November 2018 and from the French National Agency for the Safety of Medicines and Health Products (ANSM) (N° EudraCT: 2016-002444-17) in august 2018.The study is conducted in accordance with the Helsinki Declaration, the Good Clinical Practice (GCP) guidelines of the International Conference on Harmonisation (ICH–E6, 17/07/96) and local regulatory requirements. Written informed consent will be obtained for each patient before any study-related assessment starts.
: Not applicable.
: The authors declare that they have no competing interests.
